Learning Objectives

Module 1: Hormonal Contraceptive Products
At the end of this knowledge-based activity, the learner should be able to:

1. Describe how hormonal contraceptive products affect phases of the menstrual cycle to inhibit ovulation;
2. Compare and contrast the pharmacology, efficacy, clinical use, and roles in therapy of the available types of hormonal contraception, including long acting reversible contraception, barrier methods, and other hormonal contraception;
3. Identify patient-related variables that may influence the use of contraception; and
4. List non-contraceptive uses of various forms of hormonal contraceptive products, including but not limited to menstrual bleeding, dysmenorrhea, premenstrual dysphoric disorder symptoms, menstrual migraines, ovarian cysts, and acne.

Module 2: Assessing Women for Hormonal Contraception
At the completion of this application-based activity, the learner should be able to:

1. Given a patient case, including medication and medical history, and using the Maryland Self Screening Risk Assessment for Birth Control, evaluate a patient to rule out pregnancy and determine appropriateness for potential contraceptive use;
2. Given a patient case and using the United States Medical Eligibility Criteria (US MEC) and the Maryland Algorithm for hormonal contraception, assess whether a screened patient is an appropriate or at-risk candidate for hormonal contraceptives; and
3. Select the most appropriate hormonal contraceptive product based on patient- and agent-related variables.

Module 3: Communicating About Hormonal Contraceptives
At the completion of this application-based activity, the learner should be able to:

1. Formulate a plan to educate women on proper use of all the types of hormonal contraceptive products, including but not limited to when to start, missed doses, back-up methods, and adherence;
2. Formulate a plan to educate women on the risks and benefits of hormonal contraceptive products, including but not limited to warning signs, adverse events, and when to call 911;
3. List counseling strategies to reduce risk of sexually transmitted diseases and discuss the practice of safe sex;
4. List strategies on how to communicate information with other members of a patient's care team; and
5. Discuss strategies to ensure a woman has adequate follow-up with a healthcare provider or referral as needed.

Module 4: Pharmacy Practice Operations
At the completion of this application-based activity, the learner should be able to:

1. Discuss Maryland laws and regulations that allow pharmacists to prescribe hormonal contraceptives;
2. Describe a process to prescribe hormonal contraceptives in pharmacy practice;
3. Explain how to write a prescription for contraceptive products; and
4. Document patient care visits, and the Maryland visit summary related to providing hormonal contraceptive products.

Instructors

Kristine Parbuoni, PharmD, BCPPS
Associate Professor, Department of Pharmacy, Practice and Science and Director of OSCE Programs
University of Maryland School of Pharmacy
 

Charmaine Rochester-Eyeguokan, PharmD, CDE, BCPS, BCACP
Professor, Department of Pharmacy, Practice and Science
Associate Director, Clinical Services, P³ eHealth Services
University of Maryland School of Pharmacy
 

Katherine Sánchez Vega, PharmD
Clinical Pharmacy Specialist, Women's Health
Veteran Affairs Maryland Health Care System

Drs. Kristine Parbuoni, Katherine Sanchez Vega, and Charmaine Rochester-Eyeguokan, instructors for these activities, have no relevant financial relationships to disclose. None of the planners for these activities have financial relationships to disclose.

Technology Requirements

Unless otherwise noted in the course materials, the following are required to access online courses: A computer or mobile device with a stable internet connection and the ability to view and update Microsoft Word® and PowerPoint® documents.

Successful Completion:  Learners must complete all practice based activity components including the audiovisual presentations, post-tests, and activity evaluations. Participants must receive a score of at least 70% on each of the post-test in order to receive credit. Each post-test may be taken up to three (3) times. Learners must complete the activity evaluation in order to receive CE credit. A link to the activity evaluation will be available once a learner has successfully completed all other course segments. Statements of CE Credit will be available electronically via CPE Monitor within sixty (60) days of completion of the activity.  

Privacy and Confidentiality: The University of Maryland School of Pharmacy is committed to protecting the privacy of our learners. All enrollees are protected under The Family Educational Rights and Privacy Act (20 U.S.C. § 1232g; 34 CFR Part 99) (FERPA). The UMB Policy on Confidentiality and Disclosure of Student Records can be found at: https://www.umaryland.edu/policies-and-procedures/library/academic-affairs/policies/iii-630a.php.   

In order to submit your continuing education credit record to National Association of Boards of Pharmacy (NABP) CPE Monitor, we must collect personal information including, but not limited to, name, NABP ID, and date of birth. Additionally, Maryland-licensed pharmacists seeking a Contraceptive Prescribing credential must allow for submission of their activity completion record to the Maryland Board of Pharmacy.

Copyright: Resources are provided for the educational benefit of our learners and are not for distribution. All information and materials provided are the property of and have been prepared by the University of Maryland Baltimore or have been granted permission for use by the copyright owner.  No portion of this module may be reproduced or transmitted without written permission.  All rights reserved.

Use of Trade Names:  The trade names of the drugs and delivery systems in this module are for the purpose of product identification only. This activity does not intend to imply endorsement for any commercial products discussed.

• A refund, less a $75 administration fee, will be made if cancellations are made within 15 days of purchase. Other restrictions may apply.
• Refund requests must be submitted in writing to CEHelp@rx.umaryland.edu.
• Refunds are not available in the following circumstances:
  • A learner has logged into a course or series;
  • A learner has launched course materials;
  • Course materials have been shipped; or
  • Request is made after 15 days of the ordering date.
• Course registrations are non-transferrable.

Questions?  Review the Frequently Asked Questionspage.  Can't find what you are looking for?  Contact Customer Service at CEHelp@rx.umaryland.edu or 410-706-3381.